SCHEMBL7804753

SCHEMBL7804753

NCCCNc1ccc2c3c(nn2CCNCCO)-c2ccncc2C(=O)c13

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP2A P11388 4/20 0.60
ECE1 P42892 1/20 0.41
MUS81 Q96NY9 1/20 0.41
TOP2B Q02880 1/20 0.40
NSD2 O96028 2/20 0.39
FGB P02675 1/20 0.39
MMP14 P50281 1/20 0.39
TP53 P04637 4/20 0.36
BLM P54132 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
MAPT P10636 3/20 0.36
CYP3A4 P08684 2/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
TDP1 Q9NUW8 4/20 0.35
MEN1 O00255 3/20 0.35
USP2 O75604 3/20 0.35
LMNA P02545 3/20 0.35
MAPK1 P28482 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7804649 0.96 TOP2A (0.60) TOP2AECE1MUS81TOP2BNSD2
SCHEMBL7808487 0.95 TOP2A (0.60) TOP2AECE1MUS81TOP2BNSD2
SCHEMBL7812051 0.94 TOP2A (0.59) TOP2AECE1MUS81TOP2BNSD2
SCHEMBL7804428 0.94 TOP2A (0.68) TOP2AECE1MUS81TOP2BNSD2
SCHEMBL7804730 0.93 TOP2A (0.60) TOP2AECE1MUS81TOP2BNSD2
SCHEMBL7812099 0.91 TOP2A (0.60) TOP2AECE1MUS81TOP2BNSD2
SCHEMBL7811993 0.90 TOP2A (0.61) TOP2AECE1MUS81TOP2BNSD2
SCHEMBL7811716 0.90 TOP2A (0.59) TOP2AECE1MUS81TOP2BNSD2
SCHEMBL7810474 0.90 TOP2A (0.68) TOP2AECE1MUS81TOP2BNSD2
SCHEMBL7804761 0.89 TOP2A (0.60) TOP2AECE1MUS81TOP2BNSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP claimed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 US claimed
EP-0662076-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1995-07-12 EP claimed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO claimed
EP-0750619-B1 HETERO-ANNULATED INDAZOLES NOVUSPHARMA SPA (IT) 2001-05-30 EP disclosed
EP-0662076-B1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY UNIV VERMONT (US) 2001-04-11 EP disclosed
US-5604246-A HAVING POTENCY AGAINST MULTIDRUG RESISTANT TUMORS BOEHRINGER MANNHEIM ITALIA SPA (IT) 1997-02-18 US disclosed
US-5596097-A ANTITUMOR AGENTS THE UNIVERSITY OF VERMONT (US) 1997-01-21 US disclosed
EP-0750619-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA S.p.A. (IT) 1997-01-02 EP disclosed
US-5519029-A ANTITUMOR AGENTS BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1996-05-21 US disclosed
WO-1995024407-A1 HETERO-ANNULATED INDAZOLES BOEHRINGER MANNHEIM ITALIA, S.P.A. (IT) 1995-09-14 WO disclosed
EP-0662076-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1995-07-12 EP disclosed
WO-1994006795-A1 2-AMINOALKYL-5-AMINOALKYLAMINO SUBSTITUTED ISOQUINOINDAZOLE-6-(2H)-ONES WITH ANTITUMOUR ACTIVITY THE UNIVERSITY OF VERMONT (US) 1994-03-31 WO disclosed